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BRIEF REPORT

Rhabdomyosarcoma with epithelioid morphology:
A challenging cytologic diagnosis in a pleural effusion
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Abstract
Rhabdomyosarcomas (RMS) are rare malignant skeletal muscle tumors that present
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more commonly in pediatric populations. The WHO currently classifies RMS into four
types, embryonal, alveolar, pleomorphic, and spindle cell/sclerosing variants. Epitheli-
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oid rhabdomyosarcoma (EpiRMS) is another rare, recently described subtype of RMS
presenting in older patients with a male predominance and has a rapidly progressive
clinical course with frequent metastases. EpiRMS closely mimics poorly differentiated
carcinoma or melanoma, demonstrating discohesive large epithelioid cells with abundant eosinophilic cytoplasm, frequent glassy cytoplasmic inclusions, large vesicular
nuclei, and prominent nucleoli. We present a case of metastatic rhabdomyosarcoma
with features reminiscent of EpiRMS presenting as a pleural effusion, closely
followed by an inguinal lymph node biopsy. The malignant cells in the pleural fluid
were diffusely positive for desmin, negative for MyoD1, myogenin, S100 and SOX10,
and retained INI-1 expression. Subsequent lymph node biopsy demonstrated identical malignant epithelioid cells that were positive for desmin, myoD1 and myogenin,
and a cytological diagnosis of “metastatic rhabdomyosarcoma, favor epithelioid rhabdomyosarcoma” was given considering the concurrent lymph node biopsy morphology and immunoprofile. A diagnosis of rhabdomyosarcoma, though rare and
challenging, should not be overlooked when considering malignant cells with an epithelioid morphology in cytology specimens.
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I N T RO DU CT I O N

distinct variant of RMS. According to published cases, EpiRMS primarily affects older patients, median age of 70.5 years (age range 14 to

Rhabdomyosarcomas (RMS) are malignant skeletal muscle tumors that

78), with a male predilection (2:1 M:F).2 The clinical course is rapidly

are more common in pediatric populations. The WHO currently recog-

progressive with frequent regional metastasis to lymph nodes and dis-

nizes four classifications of RMS, embryonal, alveolar, pleomorphic,

tant metastasis, often to the lungs.2 EpiRMS has been reported to
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and spindle cell/sclerosing variants. Other subclassifications have

arise intramuscularly or subcutaneously in the upper and lower

also been described in the literature. All RMS subtypes demonstrate

extremities, head and neck, and trunk regions.2

morphologic and immunophenotypic features of rhabdomyoblastic

Morphologically, the diagnosis of EpiRMS can be elusive, as it

differentiation with varying clinicopathologic and histological features.

closely mimics poorly differentiated carcinoma or melanoma, demon-

Epithelioid rhabdomyosarcoma (EpiRMS)2 is a recently described,

strating discohesive large epithelioid cells with abundant eosinophilic
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cytoplasm, frequent glassy cytoplasmic inclusions, vesicular nuclei,
and prominent nucleoli.

The lymph node biopsy was concurrently assessed with the cytological specimen and demonstrated an identical population of large malig-

Renshaw, et al. previously reported an EpiRMS diagnosed in a pleu-

nant cells with epithelioid morphology, eccentrically placed nuclei,

ral effusion cytological specimen.3 We present this challenging case of

abundant pale eosinophilic cytoplasm, and prominent glassy cytoplasmic

RMS with a similar epithelioid morphology that highlights the diagnostic

inclusions (Figure 2A-C). Tumor cells were diffusely positive for desmin,

difficulty that may arise in making the cytologic diagnosis of RMS.

and in contrast to the cytological specimen, were strongly positive for
myogenin (Figure 2D) and MyoD1 (consistent with rhabdomyoblastic
differentiation). MIB1/Ki-67 revealed a high proliferation index (up to
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CASE REPORT

50%). Tumor cells were nonreactive for keratins (cytokeratin AE1/AE3,
cytokeratin 7, cytokeratin 20, cytokeratin 5/6), GATA3, PAX8, TTF-1,

A 71-year-old male presented to the emergency department with an

CDX2, NKX3.1 and PSA, calretinin, WT-1, CK5/6, caldesmon, syn-

enlarging rectal mass, night sweats, weight loss and progressive short-

aptophysin, chromogranin, with weak membranous positivity for CD56.

ness of breath over 1 month. CT and MRI pelvis with and without con-

Tumor cells retained INI-1/SMARCB1 expression. Given the morphology

trast showed a rapidly enlarging ill-defined pelvic soft tissue mass,

of the tumor cells in both the cytology and biopsy specimens, and

expanding from 3.0  4.5 cm to 11.5  8.1 cm in 20 days. Enlarged con-

immunopositivity for desmin, MyoD1 and myogenin in the biopsy tissue,

tralateral inguinal lymph nodes were also noted on imaging. CT chest

a cytological diagnosis of “metastatic rhabdomyosarcoma, favor epitheli-

with intravenous contrast showed bilateral pleural effusions with atelec-

oid rhabdomyosarcoma” was given.

tasis and multiple pulmonary nodules bilaterally, consistent with metastatic disease. Thoracocentesis and lymph node biopsies were
performed, however, the patient died 5 days later.
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The limited tissue and rapid clinical course of the patient's disease
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MATERIALS AND METHODS

precluded definitive classification of this rhabdomyosarcoma. The
unusual epithelioid morphology of this tumor was morphologically

Thoracocentesis was performed and the obtained pleural fluid was

reminiscent of recently described EpiRMS.2 On cytology, EpiRMS

prepared for cytological analysis by the ThinPrep® method and a

exhibits features of a high-grade malignancy characterized by sheets

formalin-fixed paraffin embedded cell block. Immunohistochemical

to clusters of malignant epithelioid rhabdoid cells with abundant

staining for cytokeratin AE1/AE3, desmin, MyoD1, myogenin, S100,

eosinophilic, homogeneous cytoplasm, and large vesicular nuclei with

SOX10, calretinin and INI-1/SMARCB1 was performed on separate

irregular nuclear contours.2,4 Rhabdoid inclusions, glassy eosinophilic

unstained slides from the cell block.

round cytoplasmic inclusions, with eccentrically placed nuclei may be

A subsequent ultrasound-guided inguinal lymph node biopsy was
performed 1 day later. The lymph node tissue was suspended in for-

seen. Nucleoli are prominent, similar to those seen in melanoma.
Increased mitotic figures and tumor necrosis are common.2

malin to prepare a paraffin-embedded block for histology. Sections

EpiRMS may be difficult to distinguish from other high-grade enti-

were stained with hematoxylin and eosin and immunohistochemical

ties, however, there are clues to this diagnosis. EpiRMS lacks the striking

examination was performed, with a broader panel, including anti-

pleomorphism and large multinucleated polygonal rhabdomyoblasts with

bodies towards cytokeratin AE1/AE3, cytokeratin 20, cytokeratin

dense cytoplasm and cross striations seen in pleomorphic RMS, and

7, cytokeratin 5/6, INI-1/SMARCB1, NKX3.1, CDX2, TTF-1, PAX8,

instead demonstrates cells with more size uniformity.

GATA3, PSA, myogenin, MyoD1, desmin, caldesmon, MIB1/KI67, synaptophysin, chromogranin, CD56, WT-1, and calretinin.

Embryonal RMS can demonstrate primitive mesenchymal cells in
various phases of myogenesis, and typically have alternating cellular and
myxoid areas, none of which were seen in this specimen. Differentiation
of rhabdomyoblasts can become more prominent in a posttherapy set-
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ting, however, our patient had not undergone any previous therapy.1
Alveolar RMS (ARMS), in cytology specimens, typically present

Pleural fluid cytomorphologic and cell block evaluation revealed

with discohesive monomorphic small round blue cells with scant cyto-

sheets of uniformly large, discohesive, malignant-appearing epithelioid

plasm, unlike what we find in this case. To definitely rule out ARMS,

cells (Figure 1A,B). Tumor cells had abundant eosinophilic, globular

specific molecular testing for PAX3-FOXO1 and PAX7-FOXO1 may

cytoplasm, eccentrically placed vesicular nuclei, irregular nuclear con-

be performed.1 Given these considerations, a diagnosis of RMS with

tours, and prominent nucleoli. Most cells displayed prominent

epithelioid features was favored over the WHO described subtypes.

rhabdoid cytoplasmic inclusions (Figure 1C). No cytoplasmic cross stri-

Immunohistochemical staining of EpiRMS, according to previous lit-

ations or strap cells were noted. By immunohistochemistry, the tumor

erature, exhibits focal to diffuse desmin staining and retained INI-1

cells were diffusely positive for desmin (Figure 1D) and negative for

expression.2 Furthermore, Jo, et al., reported negative S100-protein reac-

cytokeratin AE1/AE3, MyoD1, myogenin, calretinin, S100 and

tivity in all cases, and rare cytokeratin positivity in a subset (4 of

SOX10. Tumor cells retained INI-1/SMARCB1 expression.4

16 cases). There is variability in the literature regarding staining for

RODGERS ET AL.
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F I G U R E 1 A, 400- (inset Figures 600) magnification Diff-Quik-stained cytological smear shows rhabdomyoblastic cells with eccentric
nuclei and a central eosinophilic cytoplasmic globule. B, 400- Immunohistochemical staining of the cell block by desmin shows diffuse positivity
in rhabdomyoblastic cells. C, 400- and D, 600- H&E-stained section of the cell block shows discohesive large cells with abundant eosinophilic
cytoplasm, eccentric, pleomorphic nuclei, and prominent nucleoli

F I G U R E 2 A, 200- B,
400- and C, 600- H&Estained section of the lymph
node biopsy demonstrates sheets
of large epithelioid cells with
eccentrically placed nuclei,
abundant pale eosinophilic
cytoplasm with prominent glassy
cytoplasmic inclusions, and
prominent nucleoli. D, 200Immunohistochemical staining for
myogenin is seen within the
rhabdomyoblastic cells
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rhabdomyoblastic differentiation (myogenin and MyoD1)5 from negative

interpretation and manuscript writing and editing. Kyle D. Perry

to multifocal to diffusely positive immunostaining for myogenin and

contributed to report conception, data analysis and manuscript

2,3,6

MyoD1.

In broader terms, variability of staining of MyoD1 and Myo-

editing.

genin amongst the four different subtypes of RMS is described in the
WHO.1 Overall, in a limited cytological specimen with cells with rhabdoid
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morphology, it is important not to rule out RMS given inconsistent myo-

The data that support the findings of this study are available from the

genin/myoD1 staining.
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The uncommon morphology of this case illustrates the importance of considering rhabdomyosarcoma in a cytology specimen with
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malignant epithelioid cells.
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Other tumors which can exhibit a similar morphologic phenotype
include sarcomatoid carcinoma, melanoma, and malignant peripheral
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nerve sheath tumor (MPNST). In this case, immunohistochemistry rev-
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ealed no evidence of epithelial differentiation (negative for
cytokeratin AE1/AE3, cytokeratin 7, cytokeratin 20 and cytokeratin
5/6), melanocytic differentiation (negative for S100 and SOX10) or
neural differentiation (negative for SOX10 and S100) and retained
INI-1/SMARCB1 expression. While MPNST can have heterologous
differentiation (ie, Malignant Triton Tumor), the tumor tissue in our
case did not exhibit a high grade spindle cell component typically seen
in such cases. Tumor cells retained INI-1/SMARCB1 expression, arguing against other tumors, such as MPNST, proximal type epithelioid
sarcoma, and malignant extrarenal rhabdoid tumor.7,8
Careful morphologic evaluation and the pragmatic use of immunohistochemical stains are important for accurate diagnosis of rhabdomyosarcoma with epithelioid features in a cytology specimen with
limited tissue. Also, pathologists should be aware of potential inconsistent staining pattern of MyoD1 and myogenin in limited specimens.
When expanding an immunohistochemistry panel of epithelioid
tumors of unknown primary, we advise including desmin, myogenin
and MyoD1. Requesting additional tissue in order to perform a more
extensive immunostain panel should also be considered.
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